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Extracellular factors produced by Leishmania spp., Trypanosoma cruzi, and Trypanosoma brucei are important in the host-
parasite relationship. Here, we describe a genome-based approach to identify putative extracellular proteins conserved among
trypanosomatids that are likely involved in the classical secretory pathway. Potentially secreted proteins were identiﬁed by
bioinformatic analysis of the T. cruzi genome. A subset of thirteen genes encoding unknown proteins with orthologs containing
a signal peptide sequence in L. infantum, L. major, and T. brucei were transfected into L. infantum. Tagged proteins detected in
the extracellular medium conﬁrmed computer predictions in about 25% of the hits. Secretion was conﬁrmed for two L. infantum
orthologs proteins using the same experimental system. Infectivity studies of transgenic Leishmania parasites suggest that one of
the secreted proteins increases parasite replication inside macrophages. This methodology can identify conserved secreted proteins
involved in the classical secretory pathway, and they may represent potential virulence factors in trypanosomatids.
1.Introduction
The Trypanosomatidae comprise a large group of para-
sitic protozoa, some of which cause important diseases in
humans. The organisms that have been most extensively
studied are Trypanosoma brucei, the causative agent of
African sleeping sickness, T. cruzi, responsible for Chagas
disease in South America, and Leishmania spp.,w h i c hc a u s e s
Leishmaniasis in Asia, South America, and Mediterranean
countries [1]. In order to complete their life cycle, these
parasites have to adapt and develop in an insect vector
and in a vertebrate host. These single-celled organisms have
developed several strategies to modify their surrounding
environment, modulate host immune responses, or interfere
with the host’s anti-microbial activity. Materials secreted
by the parasite are involved in these processes helping
the parasite survive in an environment more favorable for
its own development [2–5]. In addition, previous studies
indicate that trypanosomatid secreted factors elicit strong
immunity and protection against infection in mice and
dogs [6, 7]. Thus secreted factors could be a source
of antigens for vaccine development, as demonstrated in
the pathogen Mycobacterium tuberculosis [8]. Nevertheless,
all trypanosomatid secreted factors involved in virulence
and/orrepresentingputativevaccinetargetsarenotcurrently
known.
The availability of three draft trypanosomatid genome
sequences provides valuable data for protein-mining using
bioinformatic tools, especially for the localization or pre-
diction of function for hypothetical proteins. Given that a
signiﬁcant number of trypanosomatid protein-coding genes
are annotated as hypothetical, additional studies are needed
to ascertain their function.
In the present study, we designed an experimental
genome-based approach to identify potentially secreted
proteinsthatareconservedamongthethreemaintrypanoso-
matid pathogens and involved in the classical secretory
pathway. We hypothesized that a phylogenetic conservation2 Journal of Biomedicine and Biotechnology
among Leishmania, T. cruzi, and T. brucei would indicate
evolutionary selection for this family of proteins and suggest
an important role for such secreted proteins in the biology
of these parasites. Our results demonstrate that the bioinfor-
matic analysis, combined with the functional tests, provides
a useful and reliable method for the identiﬁcation of novel
secreted proteins, representing potential virulence factors in
trypanosomatids. The results are also discussed in relation to
therelativeimportanceoftheclassicalandnonclassicalsecre-
torypathwaysforthereleaseofproteinsintotheextracellular
environment.
2.MaterialsandMethods
2.1. In Silico Sequence Analysis. Release V 5.0 of the T.
cruzi genome was extracted from the integrated T. cruzi
genome resource TcruziDB (http://tcruzidb.org/tcruzidb/).
Protein sequences that do not bear an initial methionine
amino acid were removed manually. Proteins belonging to
large families of surface molecules, which include trans-
sialidases, mucins, gp63s, and mucin-associated surface
proteins, were also discarded. Finally ORFs encoding
proteins bearing a molecular weight (MW) above 90
kDa were also eliminated. The software SignalP 3.0
(http://www.cbs.dtu.dk/services/SignalP/)w a su s e dt o
predict the presence of a signal peptide and a cleavage site
in amino acid sequences [9]. Protein sequences having a
signal peptide probability greater than 0.8 associated with a
cleavage site probability greater than 0.7 were analyzed for
the presence of orthologs in the related Trypanosoma brucei
and Leishmania major parasite genomes predicted by Jaccard
COG clustering in Gene DB (http://www.genedb.org/).
Most of these orthologs were conﬁrmed in TriTrypDB
(http://tritrypdb.org/tritrypdb/) using OrthoMCL and
genomic context analysis (gene synteny). The TMHMM
2.0 (http://www.cbs.dtu.dk/services/TMHMM/) and the
DAS-TMﬁlter (http://mendel.imp.ac.at/DAS/source.html)
servers were used for the prediction of transmembrane
helices in protein sequences.
2.2. Parasite Strains and Cultures. The T. cruzi TcY7 (or Y
cl7) clone derived from the Y strain [10] was used through-
out this study. Epimastigotes were grown in liver infusion
tryptose (LIT) medium supplemented with 10% FCS at
28
◦C in standard conditions [11] and harvested during
the logarithmic growth phase. Metacyclic trypomastigotes,
obtained from the diﬀerentiation of late stationary phase
epimastigotes, were used to initiate infection of mouse
ﬁbroblasts (L929). Trypomastigotes and amastigotes were
produced and harvested as previously described [12]. Pellets
for RNA puriﬁcation were processed immediately in lysis
buﬀer. The wild-type (WT) promastigote clone from L.
infantum (MHOM/MA/67/ITMAP-263) was maintained at
26
◦C by weekly subpassages in SDM 79 medium supple-
mentedwith10%heat-inactivatedFCS,100U/mLpenicillin,
and 100μg/mL streptomycin [13].
2.3. Reverse Transcription and PCR Ampliﬁcations. Total
RNA was extracted from epimastigotes, amastigotes, and
trypomastigotes with the RNeasy kit (Qiagen, Hilden, Ger-
many) according to the manufacturers’ instructions, and
t r e a t e dw i t hD N a s eI( D N A - free kit, Ambion Inc., Austin,
Texas). Reverse transcription was performed for 1μgo f
total RNA using random hexamers and Superscript II
reverse transcriptase (Invitrogen, Carlsbad, CA) according
to the manufacturers’ instructions. The cDNA (4μLo f1 / 1 0
dilutions) from each stage was ampliﬁed by PCR in a 20μL
reaction volume using 10μLo f2 XP C RM a s t e rM i x1 X
(Promega, Madison, Wisconsin) and 0.5μM gene-speciﬁc
forward and internal reverse primers (listed in Table 1) using
thefollowingcyclingconditions:94
◦Cfor3minutesfollowed
by 30 cycles of 94
◦C for 30seconds, 55
◦Ct o5 8
◦C (according
to the primer pair) for 30seconds, 72
◦C for 45seconds, and
a ﬁnal elongation at 72
◦C for 5 minutes. Amplicons were
electrophoresed on 2% agarose gels stained with ethidium
bromide.
2.4. Cloning and Sequencing. The encoding genes selected by
in silico analysis were cloned into the pTEX expression vec-
tor, carrying the Neomycin resistance gene (NEO) [14]. Full
lengthORFswereampliﬁedfromgenomicDNAwithspeciﬁc
reverse and forward primers, including diﬀerent restriction
sites and a 6-Histidine-Tag in the C-terminal region (listed
in Tables 1 and 3). PCR reactions were carried out in
20μL using 0.5μM of each primer, 0.2mM dNTP, 0.4U
of Phusion high-ﬁdelity polymerase (Finnzymes, Espoo,
Finland), and the following cycling conditions: 98
◦Cf o r3 0
secondsfollowedby25cyclesof98
◦Cfor10seconds,64
◦Ct o
68
◦C for 15 seconds, 72
◦C for 25 to 60 seconds (according to
genesize),anda72
◦Celongationfor5minutes.Digestedand
puriﬁed fragments were inserted into the dephosphorylated
pTEX vector digested with the corresponding restriction
enzymes. Cloned sequences were conﬁrmed by restriction
digestion and sequencing. Large-scale preparations of the
diﬀerent constructs were performed using the Plasmid Midi
kit (Promega).
2.5. Transfection Procedures. Promastigotes of the Leish-
mania infantum clone were electroporated as described
elsewhere [15]. Brieﬂy, promastigotes were washed twice
with HEPES-NaCl buﬀer saline (21mM HEPES, 5mM
KCl, 0.7 mM NaH2PO4, 137mM NaCl), resuspended at
108 cells/mL in HEPES-NaCl electroporation buﬀer (pH
7.2) supplemented with 6mM glucose and cooled on ice
for 10 minutes. Cells (108) were combined with 15μgo f
vector, left on ice for 10 additional minutes, and elec-
troporated using an Easyject Plus (Eurogentec, Seraing,
Belgium) apparatus set at 450V and 450μF, for one pulse.
The cells were left on ice for a further 10 minutes and
transferred to 4mL of growth medium. The antibiotic G-
418 (20μg/mL) was added 24 hours later, and parasites
were subcultured at a dilution of 1/10 in 5mL SDM in
the presence of 20μg/mL G418. Drug-resistant cells were
observed 15–20 days later. Parasites were grown in the
presence of gradually increasing concentrations of G418 and
were routinely maintained in SDM containing 150μg/mL of
G418.Journal of Biomedicine and Biotechnology 3
Table 1: Primer pairs designed to amplify the genes encoding the 13 T. cruzi putative secreted proteins conserved in trypanosomatids and
T. cruzi Tubulin (negative control).
T. cruzi GeneDB Gene ID No. Primer sequences(a) F/Rint and F/R
product sizes (bp) MW (kDa)
(b)
Tc00.1047053506417.30
F CATGAGCTTACTAGTATGTTGTCT
CTGGCAGAAGTGTGT
Rint ACGGTGCCCAAAGGCGTGTA 311
R CACACGGAAGCTTTCAATGATGATGAT
GATGATGGCGACCAAACCTAGCCATAAG 705 25.7
Tc00.1047053506155.99
F CTGGGGGAATTCATGCGGTGG
ATTTTTTTGTTACTTGCC
Rint CCGATACGTCCACCACCCCTC 336
RC G T C G G AAGCTTCTAGTGATGGTGGTG
GTGATGGACAAGTTCGTGGCATGTAATTG 735 28.1
Tc00.1047053506467.29
F ACACGGACTAGTATGATTG
TATTGAATGGAATTTCTGAG
Rint CTAATAGTCCGAAGTCGTTGCG 309
RC T A C A C AAGCTTTTAGTGATGGTGATG
GTGATGGCTGCGCCTCCACACCGTGC 1065 39.7
Tc00.1047053511901.30
F CTGATAGGCACTAGTATGTTTC
CGGCGCAGGAATTCCT
Rint CCCCTTTCAGGTGACCATTACAAGAG 316
R GCCGTCAAGCTTTTAGTGGTGGTGGTG
GTGATGCTCCGCTCCCAACTTCAAACGA 1041 39.8
Tc00.1047053511871.30
F CTGATAGGCACTAGTATGCGTC
GCACTTTATTTTGTCTG
Rint CTCTCCAACTCGTACGGCGA 305
R CTGCAGGCAAGCTTCTAATGGTGGTGATG
GTGATGTTATGATACCGGCATCAAGTCCCC 1269 47.0
Tc00.1047053505789.10
FC G C A C T C ACTAGTATGCCCTCT
GGCAAAGCAACTG
Rint TCACTGCTCCGCCCTGGTTTC 308
RC G C T C C CTCGAGTTAGTGGTGATGGTGGTG
ATGGGCAGCATTTACCGACCCTGA 1488 53.6
Tc00.1047053509669.70
F GCTCAGCCAAGCTTATGCG
CACTTCTTCTGCCGTGT
Rint ATCGGGGAGTTTTGTGCAGGTTGAG 322
R GTGGTCTTCTCGAGTTAGTGATGGTGGTG
GTGATGGTCGACTTTAATGCTCGCGTATA 1944 73.1
Tc00.1047053507765.20
F CTGCCCAGTACTAGTATGT
CTGCTAAAGCCTCACGGC
Rint TCCAGGTAGTCACCCATTCCGTG 318
RC T C A G C C AAGCTTTTAATGATGATGATG
ATGGTGTCGTCTCGCCTCACAGTGCT 1521 57.2
Tc00.1047053510101.470
F CTGCGCTGGACTAGTATG
TCTGTTAAAGCCTCACGGCG
Rint CCATTCCGTGACCGCCGTAGAC 302
R CTCGGTAAGCTTTTAATGATGATGATG
ATGGTGTCGTCTCGCCTCACAGTGCT 1518 57.3
Tc00.1047053510443.30
F CTCGCTGGAATTCATGCGGTGG
GTGATAGTTGTATTTGC
Rint CGCCAACAACGTAGTTGCCAAG 313
R ACGGACCTCGAGTTAGTGATGGTGGTG
GTGATGCTTGTTGAGTTTGGAGCGGCG 612 23.04 Journal of Biomedicine and Biotechnology
Table 1: Continued.
T. cruzi GeneDB Gene ID No. Primer sequences(a) F/Rint and F/R
product sizes (bp) MW (kDa)
(b)
Tc00.1047053509799.50
F CGCGGGACTAGTATGAAACAA
AAAATGCGACGCAAATTG
Rint GTGAGGATGGGGAACCAAAAGAGTC 297
RC A G C C AAGCTTCTAGTGATGGTGATGATG
ATGGACATTCTTCTTCTTTGTAAAGTAG 687 26.5
Tc00.1047053509835.30
F CGCGGCACTAGTATGTATT
CATGTTTGTCGCTGAGGC
Rint GCAGCAACGGCAACAAAGAGC 324
R CATGGCAAGCTTTTAGTGATGGTGGTG
GTGATGCTCCTCT CTGGGTTTCCTTCG 2031 71.6
Tc00.1047053509999.10
F CGCGCCACTAGTATGTACG
TCGTGCTTTTTTTCGTTT
Rint CGCATATTTCCGCTCCGTTCC 305
RA G C A G T C C AAGCTTTTAGTGATGGTG
ATGATGATGGCCGCACCAGCGCTCCAGAA 1227 46.6
Tc00.1047053506563.40(c)
F GGGTGCCACTAGTATGCGT
GAGATTGTGTGCGTTCAG
49.6
Rint GGGCGGAAGATCTGCCCGTATG 259
R AGCGCTCAAGCTTTTAGTGATGGTGGTG
GTGATGGTACTGCTCCTCCTCGTCGAACT 1329
F: Forward primer including the start codon; Rint: Internal reverse primer for RT-PCR; R: Reverse primer used for the ampliﬁcation of the full-length ORF.
(a)Restriction sites used for cloning in the pTEX vector in italics and the His-Tag sequence in bold.
(b)Expected molecular weight of the proteins (deduced from amino acid sequences).
(c)Beta-tubulin gene.
2.6. PCR Ampliﬁcations in Transfected Parasites. PCR ampli-
ﬁcations were carried out to check for the presence of
the NEO gene and the corresponding gene in transfected
parasites. A fragment of 800bp corresponding to the
NEO gene was ampliﬁed with speciﬁc forward and reverse
primers (F5  ATGATTGAACAAGATGGATTGCACGCA-
GG 3 ,R5   TCAGAAGAACTCGTCAAGAA 3 ).Fulllength
ORFs of the speciﬁc genes were ampliﬁed with primers listed
in Table 1.P C Rr e acti o n sw e r ec a rri edo u ti na2 0μLr e acti o n
volume using 10μL of Master Mix 1X (Promega, Madison,
Wisconsin) and 0.5μM NEO and gene-speciﬁc forward and
reverse primers using the following cycling conditions: 94
◦C
for 3 minutes followed by 30 cycles of 94
◦C for 30 seconds,
55
◦Ct o5 8
◦C (according to the primer pair) for 30 seconds,
72
◦C for 45 seconds to 2 minutes (according to gene size),
and a ﬁnal elongation at 72
◦Cf o r5m i n u t e s .
2.7. Production of Cell-Free Culture Supernatants. To analyze
the presence of secreted proteins in the supernatant, 1 ×
109 L. infantum promastigotes from log-phase culture were
collected by centrifugation, washed twice in HEPES-NaCl
buﬀer, resuspended in 40mL of HEPES-NaCl (pH 7.2),
11mM glucose, 200μg/mL G-418, and incubated for 6 hours
at 27
◦C. Parasite viability was then assessed as previously
described [16] and harvested by centrifugation at 2,100g for
10 minutes at 4◦C. The parasite pellet was stored at −80
◦C
for subsequent SDS-PAGE analysis and the supernatant was
ﬁltered through a low retention 0.45μm PVDF ﬁlter mem-
brane (Millipore, Boston, Massachusetts). After addition
of protease inhibitor cocktail (Sigma-Aldrich) the ﬁltrate
was concentrated up to 80-fold using an Ultra-Centrifugal
Filter device, according to manufacturers’ instructions
(Amicon Bioseparations, MilliporeCorp). The concentrated
cell-free culture supernatant was frozen and stored at
−80
◦C.
2.8. Production of Parasite Lysates. Cell pellets of wild-
type and episomally transfected L. infantum promastigotes
were resuspended in RIPA buﬀer (25mM Tris-HCl pH 7.6,
150mM NaCl, 1% NP-40, 1% Sodium deoxycholate and
0.1% SDS), incubated on ice for 30 minutes and sonicated
three times for 20 seconds. The soluble phase was recovered
by centrifugation at 10,000g for 30 minutes (4◦C) and
the protein concentration was determined using a Bradford
protein assay (Bio-Rad Laboratories, Hercules, California).
2.9. Gel Electrophoresis and Western Blot Analysis. Proteins
from parasite lysates (35μg) or from 80 × concentrated cell-
free supernatants (2μg )w e r es e p a r a t e do na nN u P A G EB i s -
Tris gel (4%–12%) in MOPS-SDS running buﬀer (Invitro-
gen) under reducing conditions (50mM DTT) and trans-
ferred to a PVDF membrane (Hybond-P, Amersham). The
membrane was rinsed twice in TBS and incubated for 1 hour
in the anti-His HRP conjugate blocking buﬀer (Qiagen).
The membrane was then incubated in 1/3000 anti-His HRP
conjugate antibody (Qiagen) for 1 hour and washed seven
times for 5 minutes in TBS-T buﬀer (TBS-0.5 % Tween 20).
Signals were detected by chemiluminescence emission usingJournal of Biomedicine and Biotechnology 5
the ECL Plus Western blotting detection system and ECL
Hyperﬁlms (GE Healthcare, UK).
2.10. Generation of Bioluminescent L. Infantum Promastigotes
and In Vitro Infection of Human Macrophages. Ah o m o l -
ogous episomal expression system was devised to further
examine the infection in vitro of two secreted proteins
from L. infantum.T h ev e c t o rp S P - αHYGαLUC [17]c a r -
rying the ﬁreﬂy-luciferase gene was used to cotransfect L.
infantum promastigotes overexpressing the secreted pro-
teins LinJ19.0410 (ortholog of Tc00.1047053505789.10) or
LinJ36.5780 (ortholog of. Tc00.1047053506155.99). Recom-
binant parasites were selected for their growth in increasing
concentrations of Hygromycin (up to 300μg/mL) over a
period of several weeks. Promastigotes transfected with
the pTEX vector alone and the pSP-αHYGαLUC were
used as controls for infection experiments. The survival of
transfected parasites was evaluated within human leukemia
monocyte cells (THP-1 cells). THP-1 cells were cultured
in RPMI 1640 medium supplemented with 10% FCS,
2mM glutamine, 100IU of penicillin/mL, and 100μgo f
streptomycin/mL. THP-1 cells in the log-phase of growth
were diﬀerentiated into macrophages by incubation for 2
days in a medium containing 20ng/mL of phorbol myristate
acetate (Sigma-Aldrich). THP-1 cells treated with PMA were
washed with prewarmed medium and then infected with
stationary-phase promastigotes of transfected-Leishmania in
a 24-well plate at a parasite/macrophage ratio of 10 : 1 for
4 hours at 37
◦Cw i t h5 %C O 2. Noninternalized parasites
were removed. After diﬀerent incubation periods (24 hours
to 96 hours) Luciferase activity was determined using the
Steady Glo reagent (Promega, Madison,WI), according to
the manufacturers’ instructions. After 5 minutes, the plate
was read using a Multilabel Counter VICTOR2model 1420
(Perkin Elmer). Results are expressed as the mean of RLU
(Relative Luminescence Units) activity of three independent
experiments, each performed in triplicate. Statistical signiﬁ-
cance was analyzed by the Mann-Whitney U test.
3. Results
3.1. Bioinformatic Selection for Secreted Proteins in Try-
panosomatids. The preliminary analysis of the 19613 T.
cruzi putative proteins from the CL-Brener genome was
performed to discard potential uncompleted sequences. A
total of 1796 sequences were removed manually since they
did not bear an initial methionine amino acid. The remain-
ing 17817 (90.8%) protein coding sequences were kept for
subsequent analysis. House-keeping genes and sequences
belonging to large gene families, like the trans-sialidases,
mucins, Mucin-Associated Surface Proteins (MASPs), were
discarded given that the main goal was to identify novel
secreted proteins. Finally, sequences encoding proteins with
a molecular weight above 90kDa were eliminated, in order
to facilitate subsequent gene cloning. The remaining coding
sequences were screened for the presence of both the signal
peptide and the peptidase cleavage site with a probability
of 0.8 and 0.7, respectively. A total of 216 sequences were
obtained by using these criteria. Among them, 91 (42%)
were annotated as “hypothetical proteins, conserved” in the
data bank. The ﬁnal criterion for selected proteins likely
to be secreted by the classical eukaryotic pathway was the
presence of the signal peptide and the signal peptidase site
in orthologs of the related parasites: Leishmania major, L.
infantum, and T. brucei. Among the 91 sequences, only 45
showed orthologs with the signal peptide criteria. The 13
proteins bearing the highest probability for the presence
of the signal peptide were selected (Table 2)f o rc o n ﬁ r m a -
tion of extracellular localization. Among the 13 selected
genes, Tc00.1047053505789.10 and Tc00.1047053509835.30
are homologous genes and members of a multigene family
(Table 2). These genes show about 40% identity at the
protein level and possess the same predicted orthologs in
the GeneDB server. Nevertheless in the TritrypDB resource
the prediction of orthologs is diﬀerent (see Table 2). This
could be explained by the use of diﬀerent algorithms
(Jaccard cog clustering or OrthoMCL) for the prediction
of orthologous groups [18]. The beta-tubulin T. cruzi gene
(GeneID Tc00.1047053506563) was added to our sample as
a potential negative control for protein secretion. Among
the 13 selected genes, 7 genes were predicted to have trans-
membrane domains (Table 2). These genes were included
for the functional test because previous studies identiﬁed
extracellular proteins with putative transmembrane domains
as constituents of the secretome of diﬀerent pathogens,
including L. donovani [19, 20]. Furthermore, in the protozoa
Toxoplasma gondii, the dense granule protein GRA5 is a
transmembrane protein that bears a signal peptide and is
secreted as a soluble protein into the vacuolar space, before
being inserted into the parasitophorous vacuole membrane.
Based on these studies, we included genes with potential
transmembrane domains to test whether the presence of
these domains represents a useful criterion for identifying
extracellular secreted proteins.
3.2. Transcription of the Selected Genes in the Diﬀerent
Forms of T. cruzi Life Cycle. Reverse transcription-PCR (RT-
PCR) was performed for the 13 in silico selected genes in
the diﬀerent developmental stages of T. cruzi in order to
verify transcription. The beta-tubulin T. cruzi gene (GeneID
Tc00.1047053506563), constitutively expressed in all the
threestagesofT.cruzi,wasusedasapositi v ec ontr olforRN A
quality. RT-PCR was positive for all genes in the infective
trypomastigote and amastigote forms. Two genes (Gene ID
Tc00.1047053511901.30 and Tc00.1047053509999.10) were
negative for the ampliﬁcation of cDNA in the noninfective
epimastigote form (Figure 1) suggesting a possible stage-
speciﬁc expression of these genes. Nevertheless, since try-
panosomatid gene expression is almost exclusively regulated
posttranscriptionally, further studies at the protein level have
to conﬁrm these observations.
3.3. Experimental Approach for the Detection of Secreted
Proteins. Afunctionaltestwassetuptoconﬁrmthepresence
of selected proteins in the extracellular environment by
detection of target proteins in cell-free supernatants. The 13
selected encoding genes of T. cruzi and the gene encoding the
beta-tubulin(negativecontrol)wereampliﬁedfromgenomic6 Journal of Biomedicine and Biotechnology
Table 2: T. cruzi genes selected by in silico analysis and predicted properties of the encoded hypothetical proteins.
T. cruzi GeneDB
Gene ID No.
Orthologs Probability TM(d) GPI(e) Conserved domains
(and E-value)
(f) L. major and T. brucei Gene ID No.(a) SPP(b) CSP(c)
Tc00.1047053506417.30 LmjF22.0225 Tb927.8.2180∗ 0.937 0.917 1 Yes None
Tc00.1047053506155.99 LmjF36.5220 Tb11.01.2470 0.984 0.962 0 No
Glucosidase II beta
subunit-like
(E = 1.6 e-13)
Tc00.1047053506467.29 LmjF26.2000 Tb09.160.1070 0.811 0.771 0 Yes Methyltransferase
domain (E = 4.3 e-4)
Tc00.1047053511901.30 LmjF24.2160 Tb927.8.6080 0.989 0.898 0 No
Glycerophosphoryl
diester phosphodies-
terase (E = 5.7 e-8)
Tc00.1047053511871.30 LmjF25.1010∗ Tb927.3.950∗ 0.979 0.958 0 No 2OG-Fe(II) oxygenase
(E = 1.7 e-13)
Tc00.1047053505789.10(g) LmjF19.0540∗ Tb927.8.6700(h)
1.000 0.768 5 No
Lipocalin signature
(E = 0.0)
LmjF19.0570∗ Tb11.39.0005(i)
Tc00.1047053509669.70 LmjF29.1600 Tb927.3.4190 0.999 0.980 9 No Endomembrane
protein 70 (E = 0.0)
Tc00.1047053507765.20 LmjF11.0720 Tb11.02.4400 0.993 0.986 0 No None
Tc00.1047053510101.470 LmjF11.0720 Tb11.02.4400 0.931 0.919 0 No None
Tc00.1047053510443.30 LmjF30.3150 Tb927.6.4500 0.903 0.838 1 No
Translocon-associated
protein beta (TRAPB)
(E = 4.1 e-4)
Tc00.1047053509799.50 LmjF36.5570 Tb10.6k15.1130 0.981 0.931 1 No None
Tc00.1047053509835.30(g) LmjF19.0540∗ Tb927.8.6700(h)
0.866 0.803 5 No
Heavy-metal-
associated domain,
Heavy metaltrans-
port/detoxiﬁcation
(E = 0.0)
LmjF19.0570∗ Tb11.39.0005(i)
Tc00.1047053509999.10 LmjF29.1200∗ Tb927.3.3820 1.000 0.952 3 No None
(a)L. major and T. brucei gene ID No. of putative orthologs from GeneDB.
∗Nonsyntenic predicted orthologs in the TriTrypDB server.
(b)SPP Signal peptide probability predicted by SignalP 3.0.
(c)CSP Maximal cleavage site probability predicted by SignalP 3.0.
(d)TM Number of transmembrane domains (other than peptide signal sequence) predicted by TMHMM 2.0.
(e)GPI Identiﬁcation of GPI-anchor signal by GPI-SOM.
(f)Conserved domains (and corresponding E-value) from InterPro, PROSITE or Pfam.
(g)Tc00.1047053505789.10 and Tc00.1047053509835.30 are homologous genes presenting 45% identity at the protein level. These genes are members of a
multigenefamily includingTc00.1047053505789.20, Tc00.1047053509441.10, Tc00.1047053510063.30, Tc00.1047053510065.10, and Tc00.1047053504235.9.
(h)Tb927.8.6700, Tb927.8.6710, Tb927.8.6720, and Tb927.8.6730 represent the paralogs/orthologs of Tc00.1047053505789.10, Tc00.1047053505789.20,
Tc00.1047053509441.10, Tc00.1047053510063.30, and Tc00.1047053510065.10 in the TriTrypDB server.
(i)Tb11.39.0005 represents the predicted ortholog of Tc00.1047053509835.30 and Tc00.1047053504235.9 in the TriTrypDB server.
DNA. A sequence encoding a 6xHis-Tag was added at the
C-terminal end of each encoded gene, to allow subsequent
det ectionofthepr ot einint otalparasit epr ot eine xtractsorin
concentrated cell-free supernatants (CCFSs). Ampliﬁed PCR
products were cloned into the pTEX shuttle vector widely
used for expression in trypanosomatids [14]. Transforma-
tion and selection of T. cruzi is not as easy to perform as for
Leishmania, mainly due to longer periods required for select-
ing drug-resistant parasites. Since we aimed to develop a fast
and reliable approach to identify trypanosomatid conserved
secreted proteins, we used the related Leishmania parasite
as the recipient organism for the experimental validation
of our selected proteins. Thus, L. infantum promastigotes
were separately transformed with pTEX carrying one of the
14 selected T. cruzi genes (including the beta-tubulin gene),
and the recombinant parasites were selected for resistance
to Geneticin G418. Each parasite population was checked
for the presence of both the NEOR gene and the selected
gene whose secretion was to be analyzed. A speciﬁc 800
bp fragment, indicative of the presence of the NEOR gene,
was detected in the transfected promastigotes and not in
wild-type parasites (Figure 2(a)). Moreover, the presence of
each candidate gene in recombinant parasites was conﬁrmed
using speciﬁc primers designed from T. cruzi gene sequences
(Figure 2(b)). PCRs performed on wild type Leishmania
were negative, demonstrating that the ampliﬁcation wasJournal of Biomedicine and Biotechnology 7
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Figure 1: Ampliﬁcation of the cDNAs encoding the potentially secreted proteins in the diﬀe r e n ts t a g e so fT .c r u z i :R T - P C Ra n a l y s i so ft o t a l
RNA from T. cruzi (clone derived from the Y strain) epimastigotes (E), trypomastigotes (T), and amastigotes (A). cDNA was ampliﬁed using
gene-speciﬁc PCR primers (Listed in Table 1). Gene ID and expected lengths of cDNA are listed in order in Table 1. M: Molecular marker:
Smart Ladder SF.
genus speciﬁc although the genes are conserved in both
trypanosomatids (data not shown). The expression of these
genes was screened using an antibody directed against the
His-Tag carried by the recombinant proteins (Figure 3(a)).
Western blot analysis demonstrated that (i) it was possible
to easily and speciﬁcally detect the 6xHis tag protein in the
extractderivedfromrecombinantparasites,(ii)recombinant
Leishmania expressed a relatively high level of T. cruzi
protein, and (iii) the molecular weight of the detected tagged
protein corresponded to the expected MW (see Table 1).
Subsequently, an approach was set up to detect recom-
binant proteins in cell-free supernatants. In order to
limit potential contamination by proteins derived from
dying organisms, incubation in serum-free mediums was
restricted to 6 hours, and the viability of parasite popula-
tions was checked before and after this incubation period.
Parasites and cell-free supernatants were collected if the
viability of the cell population was above 98%. Western
Blot analysis of the concentrated cell-free supernatants
revealed that among the 14 proteins, only 3 were actively
secreted (Tc00.1047053506155.99, Tc00.1047053505789.10,
and Tc00.1047053509999.10) (Figure 3(b)). These proteins
represent genuine secreted material, since (i) the overexpres-
sion of the beta-tubulin gene does not induce translocation
of the beta-tubulin protein into the extracellular space
(diﬀerence between Lys and CCFS in Figure 3(b)), and
(ii) the detection of the tagged protein in the cell-free
supernatant is not related to the level of its expression
by Leishmania (low abundance of Tc00.1047053506155.99
in Figure 3(b)). As expected, a slight molecular weight
diﬀerence was observed between the tagged protein detected
into the whole soluble extract and that detected in the
cell-free supernatant that could be explained by the loss
of the Signal Peptide (Figure 3(b)). As anticipated, no
cross-reactive band was detected in wild-type parasites
(Figure 3(b)). To conﬁrm that the secretion observed was
not related to the heterologous expression system, two
Leishmania genes (Gene ID LinJ19.0410 and LinJ36.5780)
corresponding to the orthologs of Tc00.1047053505789.10
and Tc00.1047053506155.99 genes were selected to validate8 Journal of Biomedicine and Biotechnology
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Figure 2: PCR analyses in episomally transfected L. infantum promastigotes. (a)Ampliﬁcation of NEO gene fragment in L. infantum
episomally transfected promastigotes. (b) Ampliﬁcation of full length transfected genes in L. infantum promastigotes. Speciﬁc forward and
Reverse PCR primers and gene lengths are listed in order in Table 1. WT: Wild Type Parasites. M: Molecular marker: Smart Ladder SL.
our approach. By using the same protocol as above, Leish-
mania expressing the 6xHis tagged proteins were generated
(See Table 3). As expected, the presence of the tagged
protein in the extracellular medium was only detected in the
episomally transfected parasites (Figure 4). Together, these
results indicate that this approach allows the identiﬁcation
of new and genuinely extracellular proteins involved in the
endoplasmic reticulum/Golgi-dependent secretory pathway.
3.4. Expression of Secreted Proteins Increases Ability of
Recombinant Leishmania Parasites to Infect and Survive
inside Macrophages In Vitro. We attempted to determine
whether the expression of Leishmania-secreted proteins
could interfere with the capacity of recombinant parasites
to replicate within human macrophages in vitro. Both
conﬁrmed secreted proteins (LinJ19.0410 and LinJ36.5780)
from L. infantum were tested by using the luciferase reporter
system in transfected parasites overexpressing these proteins.
We used bioluminescence as a quantitative indicator of
the viability and multiplication of parasites. The number
of promastigotes cells and luciferase activity were linearly
correlated for the diﬀerent recombinant parasites before
macrophage infection (data not shown). Results of in vitro
infection showed that overexpression of secreted protein
LinJ19.0410 (ortholog of Tc00.1047053505789.10) increases
the capacity of Leishmania to survive in THP-1 diﬀerentiated
macrophages as early as 24 hours postinfection (Figure 5).
Furthermore, a statistically signiﬁcant increase in luciferase
activity of recombinant parasites expressing LinJ19.0410
was maintained throughout the experiments (P<. 05).
This eﬀect was not observed in parasites overexpressing
LinJ36.5780 (ortholog of Tc00.1047053506155.99) where
infectivity levels were similar to the control parasites trans-
fected with the pTEX vector alone and the pSP-αHYGαLUC
(Figure 5).
4. Discussion
In trypanosomatids the secretion process is not fully
understood and various pathways including classical and
nonclassical mechanisms may contribute to the formation
of the “extracellular proteome.” Thus the individual identi-
ﬁ c a t i o no fs e c r e t e dm a t e r i a l sw o u l de n h a n c ee ﬀorts towards
understanding mechanisms of protein secretion in these
medically important parasites. In an attempt to provide a
new approach to analyse the large number of hypothetical
conserved proteins in trypanosomatids, we developed an
experimental approach to identify hypothetical extracellular
proteins likely to be involved in the classical pathway. We
combined a web-based bioinformatics approach that used
theSignalP3.0program,oneofthemostaccuratepredictors
for the presence of a signal peptide sequence [21], withJournal of Biomedicine and Biotechnology 9
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Figure 3: Protein expression in L. infantum episomally transfected promastigotes during the exponential phase of development (a) Western
blot analysis of His-tagged proteins detected in whole cell lysate. Equal amounts of total protein (35μg) were resolved by electrophoresis
in 4–12% gradient gels (Invitrogen), blotted, and developed with anti-HisTag antibody followed by ECL (Amersham). Gene ID and the
theoretical molecular weight of detected proteins are listed in order in Table 1. (b) Identiﬁcation of secreted proteins in whole cell lysate
(Lys) and concentrated cell-free culture supernatant (CCFS) obtained from promastigotes incubated for 6 hours in serum-free medium.
Note the absence of β Tubulin in the concentrated supernatant of Line 8. Nontransfected L. infantum promastigotes (Wild Type) were used
as a negative control. Protein molecular mass standards in kDa are shown on the left of each panel.
a functional test that takes advantage of the relative ease
to genetically transform Leishmania. We assumed that a
phylogenetic conservation among Leishmania, T. cruzi, and
T. brucei wouldpointtoevolutionaryselectionforthisfamily
of proteins and indicate an important role for these proteins
in the biology of these parasites. Using these criteria we
selectedapoolof13trypanosomatid-conservedhypothetical
proteins from the T. cruzi database for which secretion was
tested.
Identiﬁcation of secreted proteins has been hampered
in trypanosomatids due to the diﬃculty in distinguishing
genuine secretions from molecules released by lysed, dead,
or dying organisms. Additionally, the in vitro growth of try-
panosomatid developmental stages that occur in mammals is
impossible or laborious.
Characterization by screening cDNA libraries with sera
raised against culture medium supernatants has been
performed for the identiﬁcation of extracellular proteins10 Journal of Biomedicine and Biotechnology
Table 3: Gene ID of L. infantum orthologous genes and primers used for cloning.
Gene ID Primer sequences(a) F/R product sizes (bp) MW(kDa)(b)
LinJ19.0410(c) FC A T G A C C ACTAGTATGGCCAAAACAGCGCTTCTC 1590 58,4
R GCAGTCCAAGCTTTTAGTGATGGTGATGATGATG
AGGTGTTCTCAGGGGTGACGA
LinJ36.5780(d) FCA T GCT CGACTAGTATGGGGTGCCGCAGTAGCTG
R GCAGTCCAAGCTTTTAATGATGATGGTGGTGATG
ATCATCCAACATCTGGCACCGC
738 28
F: Forward primer including the start codon; R: Reverse primer used for the ampliﬁcation of the full-length ORF.
(a)Restriction sites used for cloning in the pTEX vector in italics and the His-Tag sequence in bold.
(b)Expected molecular weight of the proteins.
(c)Ortholog of LmjF19.0540 and Tc00.1047053505789.10.
(d)Ortholog of LmjF36.5220 and Tc00.1047053506155.99.
CCFS Lys
LinJ19.0410
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Figure 4: Homologous expression of secreted proteins in L. infantum episomally transfected promastigotes. L. infantum pro-
mastigotes were transfected with genes LinJ19.0410 and LinJ36.5780 corresponding to secreted proteins Tc00.1047053505789.10 and
Tc00.1047053506155.99, respectively. Cell whole lysate (Lys) and concentrated cell-free culture supernatant (CCFS) and electrophoresis
procedure were as in Figure 3. Tagged proteins were detected only in recombinant parasites transfected with LinJ19.0410 (58 kDa) (Line 1
and 2) and LinJ36.5780 (28 kDa) (Line 3 and 4). Nontransfected L. infantum promastigotes (Wild Type) were used as negative controls (Line
5 and 6). Protein molecular mass standards in kDa are shown on the left.
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Figure 5: Bioluminescence activity of intracellular Leishmania expressing episomal luciferase from infected macrophages in vitro.
Recombinant L. infantum promastigotes overexpressing the secreted proteins pTEX-LinJ19.0410 () or pTEX-LinJ36.5780 (•)w e r e
cotransfected with the pSP-YαHYGROαLUC carrying the ﬁreﬂy-luciferase gene. Survival of luciferase-expressing parasites was monitored
in infected human monocyte cell line THP-1 diﬀerentiated into macrophages as indicated in the Methods section. Promastigotes transfected
with the pTEX vector alone and the pSP-αHYGαLUC () were used as control for infection experiments. RLUs (Relative Luminescence
Units) were measured at various time points post infection using the Steady Glo reagent. Results are expressed as the mean of three
independent experiments, each carried out in triplicate.Journal of Biomedicine and Biotechnology 11
[22, 23]. However, using this approach proteins with a
low abundance or that are poorly immunogenic are likely
to be missed. A more exhaustive approach relying on a
highly sensitive methodology, like the quantitative mass
spectrometry, was recently used to analyze the protein
content of the whole conditioned medium from stationary-
phase L. donovani promastigotes [19]. Nevertheless, proteins
produced at low abundance and that are mainly exported
to the extracellular compartment are likely to be missed,
since the method relies on the comparison of conditioned
medium versus cell-associated proteins. Indeed proteins that
are well known to be extracellular, such as chitinase and
SAcP (secreted acid phosphatase), were not identiﬁed with
the SILAC-based approach [19] .T h em e t h o dw ed e s i g n e d
allowed us to identify three new trypanosomatid conserved
proteins, likely to be secreted through the classical secretory
pathway. We were conﬁdent that the proteins detected in
the cell-free supernatant were genuinely secreted since (i)
we were not able to detect the beta-tubulin-tagged protein
in the cell-free supernatant after overexpression of the
gene, (ii) the 6-hour incubation time avoided excessive cell
death and contamination by proteins released from dead
parasites, (iii) in the extracellular environment we detected
orthologous Leishmania proteins (LinJ19.0410, LinJ36.5780)
suggesting that secretion in this protein family is likely
to be evolutionary conserved, and (iv) we detected no
relation between the amount of secreted protein and its
intracellular expression in the transfected parasites, demon-
strating that the translocation of the his-tagged protein into
the cell supernatant is not related to the methodology we
used.
A recent study involving conditioned medium derived
from stationary-phase Leishmania promastigotes [19]
demonstrated that the extracellular proteome was mainly
composed of proteins derived from diﬀerent microvesicles.
The parasite growth phase studied by these authors
contains the infectious metacyclic parasites and also a
high percentage of dying parasites in apoptosis [24].
Consequently, the analysis of extracellular material revealed
that the main contributors to the “extracellular proteome”
are vesicles likely to be “apoptotic vesicles” or “blebs” [25].
This work leads to the general conclusion that 98% of the
proteins of the Leishmania secretome lacked a targeting
signal, indicating that nonclassical secretion pathways
are likely to be the dominant way by which Leishmania
export proteins [19]. The proteomic characterization of the
released/secreted proteins of L. braziliensis promastigotes
showed that about 5% of the identiﬁed proteins possess
a putative N-Signal peptide [26], indicating that protein
export may depend on unconventional pathways as
suggested in L. donovani.H o w e v e r ,s o m ee v i d e n c es t r o n g l y
supports the notion that the classical secretory pathway
is operational in trypanosomatids and contributes to the
composition of the parasite’s secretome. For example, the
screening of an L. major cDNA library with antiserum
raised against culture supernatant from stationary-phase
promastigotes led to the detection of 8 proteins bearing
a potential signal peptide among the 33 genes identiﬁed
[23]. Moreover some of the well-known Leishmania proteins
found in the extracellular environment have a signal
peptide for secretion, such as gp63 or chitinase [3, 27].
In the current work we deliberately decided to experimen-
tally validate the secretion of our candidate proteins during
the exponential growth phase of Leishmania in order
to avoid contamination of the cell-free supernatant by
apoptotic vesicles or exosomes. In these conditions we did
not detect the secretion of tubulin, even in an overexpression
model of Leishmania transfectants, while tubulin was
identiﬁed with a signiﬁcant score in the Leishmania
secretome studied by the proteomic analysis performed
during the stationary-phase [19]. Therefore, our results
suggest that tubulin might be associated with exosomes
and/or apoptotic vesicles generated by promastigotes
in the stationary-phase of growth. We suggest that the
composition of the parasite “extracellular proteome” is
variable and depends both on the parasite stage under
consideration and on the relative contribution of the various
pathways operating in protein secretion. Further studies are
required to highlight the importance of both classical and
nonclassical secretory pathways in diﬀerent developmental
stages of trypanosomatids. Since we selected and tested
secretion for several genes in the trypanosomatid genomes,
our methodology provides a potential tool for genomewide
screening to identify extracellular proteins. Furthermore,
our methodology may complement other strategies, such
as the SILAC approach, for the identiﬁcation of proteins
missed when using proteomic-based approaches.
Regarding proteins not detected in the extracellular
environment, it is important to point out that proteins
bearing a signal peptide are not only targets for secretion
but also for transfer to speciﬁc organelles, for example,
lysosomes or the cell surface. Thus, these proteins could
be retained in speciﬁc organelles within the parasite or
attach to the cell surface via a GPI-anchor. In this light,
analysis of the 13 proteins with GPI-SOM [28] suggests
that 2 out of 13 proteins (Tc00.1047053506417.30 and
Tc00.1047053506467.29) have a predicted glycosyl-inositol
phosphate (GPI) anchor signature sequences. Hence, the
presence of the GPI anchored domain may explain the
absence of these proteins in the culture supernatant of
recombinant parasites.
An unexpected ﬁnding in our results was the prediction
of transmembrane helices in two of our secreted proteins
(Tc00.1047053505789.10 and Tc00.1047053509999.10). We
included proteins with transmembrane domains to test
whether their presence in protein sequences is a suitable
criterion for the prediction of extracellular secreted proteins.
Previous studies suggested that the presence of transmem-
brane helices in protein sequences is not a suitable criterion
for discarding potentially secreted proteins [19, 20]. In this
regard our results provide further evidence that empirical
studies are required to verify bioinformatic predictions
since two of the extracellular proteins bear transmemebrane
domains. However, another speculative explanation for
the presence of transmembrane domains is the potential
insertion of secreted materials into membranes after secre-
tion, as demonstrated for the pathogen Toxoplasma gondii
[29, 30].12 Journal of Biomedicine and Biotechnology
The secreted protein Tc00.1047053505789.10 contains
a lipocalin signature. Lipocalins are a widely distributed
group of mostly extracellular proteins, several of which
have been implicated in the regulation of host immune
responses, such as, alpha-1-microglobulin and alpha-1-acid
glycoprotein[31].Despiteawell-conservedtertiarystructure
of lipocalins, the pairwise sequence identity within this
family is low, often below 30%, [32]. This may explain
the absence of a predicted lipocalin signature in the
Leishmania spp. or T. brucei orthologs. Remarkably, the
protein encoded by Tc00.1047053509835.30 (homolog of
Tc00.1047053505789.10) lacks a lipocalin signature. Fur-
thermore, this protein was not detected as extracellular in
our experimental conditions. Although these genes belong
to a multigene family (see Table 2) and possess about
40% identity at the protein level, our ﬁndings suggest
ad i ﬀerent cellular localization and/or function for the
corresponding proteins. A clear assignment of the protein
Tc00.1047053505789.10 to the lipocalin family would only
be possible after NMR or X-ray crystallography structure
analysis. Further studies are needed to ascertain if this large
and diverse group of proteins is present in trypanosomatids
and plays a role in the transmission process. A Glucosidase
II beta subunit-like protein domain has also been detected
in the protein Tc00.1047053506155.99. Although mostly
localized to the ER, Glucosidase II was found in endocytic
structures beneath the plasma membrane and has been
associated with the protein-tyrosine phosphatase CD45 [33].
There is also evidence that in some cell types Glucosidase II
beta is capable of being traﬃcked to the cell surface [34].
Having demonstrated that our methodology is reliable
for the identiﬁcation of extracellular secreted proteins in
trypanosomatids, we tested the hypothesis that recombinant
Leishmania parasites carrying extra copies of Leishmania
secreted proteins may interfere with their survival or infec-
tivity towards human monocyte-derived macrophages in
vitro. Results of these assays showed a signiﬁcant survival
advantage to Leishmania parasites overexpressing the gene
LinJ19.0410 (Ortholog of Tc00.1047053505789.10) suggest-
ing that this protein is involved in a process increasing
survival and/or replication of the parasite inside its target
cell. Given that Leishmania and T. cruzi do not target the
same host cells and follow diﬀerent cell invasion processes,
further experiments in the T. cruzi homologous system are
needed to address whether the identiﬁed secreted protein
Tc00.1047053505789.10 from T. cruzi is also involved in
host cell invasion and/or replication. Current in vitro and
in vivo studies are in progress to characterize this protein
which represents a potential conserved virulence factor in
trypanosomatids.
5. Conclusions
In conclusion, our results show that the bioinformatics
method combined with the functional tests, provides a
fast and reliable method for the identiﬁcation of novel
extracellular secreted proteins involved in the classical secre-
tory pathway and represents potential virulence factors in
trypanosomatids.
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